![Mark Avagliano](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Mark Avagliano worked as the Vice President & Head-Corporate Development at Pfizer Inc. from 2004 to 2019.
He then served as the Chief Business Officer at G1 Therapeutics, Inc. from 2019 to 2024.
Mr. Avagliano holds a graduate degree from the University of Oxford, an undergraduate degree from Marist College, and another graduate degree from the London School of Economics & Political Science.
Anciens postes connus de Mark Avagliano
| Sociétés | Poste | Fin |
|---|---|---|
| G1 THERAPEUTICS, INC. | Corporate Officer/Principal | 18/09/2024 |
| PFIZER INC. | Corporate Officer/Principal | 01/07/2019 |
Formation de Mark Avagliano
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
87
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Marist College
 Marist College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
London School of Economics & Political Science
 London School of Economics & Political Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
G1 Therapeutics, Inc.
 G1 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for cancer treatment | Health Technology |
Choisissez Zonebourse 
